Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Patient Reported Outcomes Version of CTCAE

Known as: PRO-CTCAE, Patient-Reported Outcomes version of the CTCAE (PRO-CTCAE) 
A library of items for patient self-reporting of symptoms and side effects associated with cancer treatment trials.(PRO-CTCAE)
National Institutes of Health

Related topics

Related topics

13 relations
NonePast Seven Days Feeling Nothing Could Cheer You Up Interfering with Usual or Daily ActivitiesPast Seven Days Frequency of HiccupsPast Seven Days Frequency of Sad or Unhappy Feelings
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
The Japanese version of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE): psychometric validation and discordance…
BackgroundThe Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) was developed… Expand
  • figure 1
  • table 1
  • table 1
  • figure 2
  • table 3
2018
2018
Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048.
Purpose The US National Cancer Institute (NCI) Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse… Expand
Review
2017
Review
2017
Japanese translation and linguistic validation of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
BackgroundThe US National Cancer Institute (NCI) has developed the Patient-Reported Outcomes version of the Common Terminology… Expand
  • table 1
  • table 2
  • table 2
  • table 2
  • table 3
2017
2017
Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy…
PURPOSE To assess the feasibility of measuring symptomatic adverse events (AEs) in a multicenter clinical trial using the… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
2017
2017
Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient‐Reported Outcomes version of the Common Terminology Criteria for…
Adverse event (AE) reporting in oncology trials is required, but current practice does not directly integrate the child's voice… Expand
Review
2016
Review
2016
Patient-Reported Outcomes in Cancer Clinical Trials: Measuring Symptomatic Adverse Events With the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for…
Systematic capture of the patient perspective can inform the development of new cancer therapies. Patient-reported outcomes (PROs… Expand
Highly Cited
2015
Highly Cited
2015
Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
IMPORTANCE To integrate the patient perspective into adverse event reporting, the National Cancer Institute developed a patient… Expand
Highly Cited
2015
Highly Cited
2015
Phase 2 Trial of De-intensified Chemoradiation Therapy for Favorable-Risk Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
PURPOSE To perform a prospective, multi-institutional, phase 2 study of a substantial decrease in concurrent chemoradiation… Expand
Highly Cited
2015
Highly Cited
2015
PROceeding With the Patient-Reported Outcomes (PROs) Version of the Common Terminology Criteria for Adverse Events.
  • B. Movsas
  • JAMA oncology
  • 2015
    • Corpus ID: 205126718
For more than 30 years, the standard process for reporting toxicities in clinical oncology trials has been via the National… Expand
Highly Cited
2013
Highly Cited
2013
Cognitive interviewing of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
PurposeThe National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events… Expand
  • table 1
  • table 1
  • table 1
  • table 2
  • figure 1
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE